Shilzia Munguambe
Shilzia Munguambe publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Diagnosis and treatment of tuberculosis and Pneumonia and Respiratory Infections.
- World rank
- #1,996,735 of 7,710,434 ranked researchers
- Rank in Mozambique
- #124 of 615
- Works
- 26
- Citations
- 164
- Citations per work
- 6.3
What does Shilzia Munguambe research?
Shilzia Munguambe's work is mostly in Medicine (82%), Engineering (4%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2181.9%
- Medicine2181.9%
- Everything else311.6%
- Physical Sciences13.9%
- Engineering13.9%
- Life Sciences12.6%
- 1Infectious Diseases35% of their works
- 2Epidemiology26% of their works
- 3Surgery21% of their works
- 4Applied Microbiology and Biotechnology3% of their works
- 5Biomedical Engineering3% of their works
- 6Media Technology1% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Diagnosis and treatment of tuberculosis
- Pneumonia and Respiratory Infections
- Infectious Diseases and Tuberculosis
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Antibiotic Use and Resistance
- Biomedical Text Mining and Ontologies
Which keywords describe Shilzia Munguambe's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Drug Resistance, Mycobacterium tuberculosis, Tuberculosis, Clinical Practice Guidelines and Antiretroviral Therapy.
- Biomedical Ontologies
- Antimicrobial Stewardship
- Pneumocystis
- Mycobacterium avium
- Spinal Epidural Abscess
- Pneumococcal Conjugate Vaccine
- Diagnostic Challenges
- Antiretroviral Therapy
- Tuberculosis
- Drug Resistance
- Diagnosis
- Epidemiology
- Treatment
- Mycobacterium tuberculosis
- Clinical Practice Guidelines
- Abdominal Tuberculosis
- Community-Acquired Pneumonia
- Antibiotic Resistance
- Tuberculous Meningitis
- Nontuberculous Mycobacteria
- Pneumonia
- Global Health
- Text Mining
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Epidemiology455 topics
- Diagnosis353 topics
- Treatment353 topics
- Drug Resistance272 topics
- Mycobacterium tuberculosis251 topic
- Tuberculosis251 topic
- Clinical Practice Guidelines152 topics
- Antiretroviral Therapy122 topics
- Abdominal Tuberculosis91 topic
- Diagnostic Challenges91 topic
- Community-Acquired Pneumonia81 topic
- Pneumococcal Conjugate Vaccine81 topic
- Antibiotic Resistance72 topics
- Spinal Epidural Abscess71 topic
- Tuberculous Meningitis71 topic
- Mycobacterium avium51 topic
- Nontuberculous Mycobacteria51 topic
- Pneumocystis51 topic
- Pneumonia51 topic
- Antimicrobial Stewardship21 topic
- Global Health21 topic
- Biomedical Ontologies11 topic
- Text Mining11 topic
Where does Shilzia Munguambe work?
Shilzia Munguambe's main affiliation in the publication record is Manhiça Health Research Centre, Mozambique.
How many publications and citations does Shilzia Munguambe have?
OpenAlex counts 26 works and 164 citations for Shilzia Munguambe, an h-index of 8, ranking #1,996,735 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shilzia Munguambe. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.